|
MedChemExpress
dna pk inhibitor ![]() Dna Pk Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dna pk inhibitor/product/MedChemExpress Average 95 stars, based on 1 article reviews
dna pk inhibitor - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
Vazyme Biotech Co
6200 fastpure dna isolation mini kit vazyme biotech cat ![]() 6200 Fastpure Dna Isolation Mini Kit Vazyme Biotech Cat, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/6200 fastpure dna isolation mini kit vazyme biotech cat/product/Vazyme Biotech Co Average 97 stars, based on 1 article reviews
6200 fastpure dna isolation mini kit vazyme biotech cat - by Bioz Stars,
2026-03
97/100 stars
|
Buy from Supplier |
|
Boster Bio
anti dna pk pser2056 ![]() Anti Dna Pk Pser2056, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti dna pk pser2056/product/Boster Bio Average 93 stars, based on 1 article reviews
anti dna pk pser2056 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
TargetMol
dna pk inhibitor ![]() Dna Pk Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dna pk inhibitor/product/TargetMol Average 94 stars, based on 1 article reviews
dna pk inhibitor - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
MedChemExpress
treatment dna pk inhibitor azd7648 ![]() Treatment Dna Pk Inhibitor Azd7648, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/treatment dna pk inhibitor azd7648/product/MedChemExpress Average 95 stars, based on 1 article reviews
treatment dna pk inhibitor azd7648 - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
dna pk inhibitor azd7648 ![]() Dna Pk Inhibitor Azd7648, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dna pk inhibitor azd7648/product/MedChemExpress Average 95 stars, based on 1 article reviews
dna pk inhibitor azd7648 - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
MedChemExpress
dna pk inhibitors ku 0060648 ![]() Dna Pk Inhibitors Ku 0060648, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dna pk inhibitors ku 0060648/product/MedChemExpress Average 93 stars, based on 1 article reviews
dna pk inhibitors ku 0060648 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Zymo Research
pk 6100 zymo chip dna clean concentrator zymo research ![]() Pk 6100 Zymo Chip Dna Clean Concentrator Zymo Research, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pk 6100 zymo chip dna clean concentrator zymo research/product/Zymo Research Average 99 stars, based on 1 article reviews
pk 6100 zymo chip dna clean concentrator zymo research - by Bioz Stars,
2026-03
99/100 stars
|
Buy from Supplier |
Journal: PLOS Biology
Article Title: DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation
doi: 10.1371/journal.pbio.3003621
Figure Lengend Snippet: (A) Immunofluorescence microscopy quantification of NFκB translocation, phosphorylated SP1 residue Ser101, phosphorylated cJun residues Ser63 and Ser73, and phosphorylated RNA polymerase II residues Ser2 and Ser5 in differentiated THP1 cells infected with Vpr WT or control viruses in the presence or absence of ATM, ATR, or DNA-PK inhibition ( n = 50 cells). Cells were infected for 24 hours, treated with vehicle or the indicated inhibitor for 24 hours, and then subjected to immunofluorescence microscopy. Analyses were performed using a one-way ANOVA; ns, not significant; ** p < 0.01; *** p < 0.001. The data underlying this Figure can be found in . (B) Representative immunofluorescence microscopy images of R-loop abundance in primary MDM and HeLa cells infected with indicated viruses 48 hours post-infection ( n = 50 cells). Analyses performed using a student t test; *** p < 0.001. (C–E) Immunofluorescence microscopy quantification of R-loop abundance in HeLa cells infected with indicated viruses 48 hours post-infection. Samples were left untreated (C) or treated with RNaseH (D, left), triptolide (D, right), or with the indicated DDR inhibitors (E), respectively ( n = 50 cells). For RNaseH treatment, cells were infected for 48 hours prior to methanol fixation and addition of recombinant RNaseH to deplete RNA associated with R-loops. For inhibitor treatments, HeLa cells were infected for 24 hours, treated with the indicated inhibitor for 24 hours, and then subjected to immunofluorescence microscopy. Analyses were performed using a one-way ANOVA; ns, not significant; ** p < 0.01; *** p < 0.001. The data underlying this Figure can be found in . (F) Immunofluorescence microscopy quantification of DDR activation (left) and R-loop abundance (right) in HeLa cells infected with indicated viruses and transfected with RNaseH constructs ( n = 50 cells). Cells were infected for 24 hours before transfection of control or RNaseH-expressing plasmids for 24 hours prior to being prepared for immunofluorescence microscopy. Analyses performed using a one-way ANOVA; ns, not significant; *** p < 0.001; * p < 0.05. The data underlying this Figure can be found in . (G) Flow cytometric histograms of HeLa cells infected with control or Vpr WT LTR-mCh viruses for 24 hours prior to transient expression of RNaseH for 24 hours and quantification of LTR-mCh MFI in transfected cells via flow cytometry ( n = 3 experiments). Analyses performed using a one-way ANOVA; ns, not significant; *** p < 0.001. The data underlying this Figure can be found in . Representative gating strategies are depicted in and raw FSC files can be found in the Figshare Data repository ( https://doi.org/10.6084/m9.figshare.c.8239897 ).
Article Snippet: For inhibitor experiments, cells were treated 24-hours post-infection with either 10 nM ATM inhibitor (Fisher, #AZD1390), 10 μM ATR inhibitor (Fisher, #NU6027), 3 mM caffeine, 16 μM
Techniques: Immunofluorescence, Microscopy, Translocation Assay, Residue, Infection, Control, Inhibition, Recombinant, Activation Assay, Transfection, Construct, Expressing, Flow Cytometry
Journal: Nature Communications
Article Title: Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR
doi: 10.1038/s41467-025-65182-4
Figure Lengend Snippet: Characterisation of aberrations induced by repair inhibitors on Cas9 edited HSPCs targeting the CCR5 locus. a Summary comparison between CLEAR-time dPCR (top) and ICE (bottom) 1, 3, and 14-days post-editing. Rel. indels = relative indels. For CLEAR-time dPCR, data are shown as mean ± s.d. For ICE, data are shown as n = 1. b Quantification of sequence trimming around the cleavage site in CCR5 edited HSPCs 1, 3, and 14-days post-editing. Data are shown as mean ± s.d. c CLEAR-time dPCR summary of aberrations induced by repair inhibitors on Cas9 edited iPSCs (top) and HSPCs (bottom) targeting the CD34 locus with and without an ssODN 3, 7, and 14-days post-editing. Data are shown as mean ± s.d. d Quantification of sequence trimming around the cleavage site of CD34 edited iPSCs (top) and HSPCs (bottom) 1, 3, and 14-days post-editing. Data are shown as mean ± s.d. e Comparison between ICE (I) and CLEAR-time dPCR (Ct) in Cas9 edited T cells (top), HSPCs (middle), and iPSCs (bottom) targeting the CCR5 locus with and without AAV transduction and AZD7648 treatment 4-days post-editing. Data are shown as mean ± s.d. ( n = 3 technical replicates of 2 independent donors per cell type). All data represents n = 3 technical replicates unless stated otherwise. b , d Two-way ANOVA with Tukey post-hoc test., n.s.= non-significant, **** p < 0.001. Source data are provided as a Source Data file.
Article Snippet:
Techniques: Comparison, Sequencing, Transduction